PHASE II TRIAL OF NEO-ADJUVANT TEMOZOLOMIDE PRIOR TO COMBINED TEMOZOLOMIDE AND CONCURRENT ACCELERATED HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY FOLLOWED BY ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: